Cargando…

The Role of MET Inhibitor Therapies in the Treatment of Advanced Non-Small Cell Lung Cancer

Introduction: Non-small cell lung cancer (NSCLC) is the second most common cancer globally. The mesenchymal-epithelial transition (MET) proto-oncogene can be targeted in NSCLC patients. Methods: We performed a literature search on PubMed in December 2019 for studies on MET inhibitors and NSCLC. Phas...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Mello, Ramon Andrade, Neves, Nathália Moisés, Amaral, Giovanna Araújo, Lippo, Estela Gudin, Castelo-Branco, Pedro, Pozza, Daniel Humberto, Tajima, Carla Chizuru, Antoniou, Georgios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356188/ https://www.ncbi.nlm.nih.gov/pubmed/32575417 http://dx.doi.org/10.3390/jcm9061918

Ejemplares similares

New Target Therapies in Advanced Non-Small Cell Lung Cancer: A Review of the Literature and Future Perspectives
por: de Mello, Ramon Andrade, et al.
Publicado: (2020)

Current and future aspects of TIM-3 as biomarker or as potential targeted in non-small cell lung cancer scope: is there a role in clinical practice?
por: De Mello, Ramon Andrade, et al.
Publicado: (2020)

Immunotherapy in Patients with Advanced Non-Small Cell Lung Cancer Lacking Driver Mutations and Future Perspectives
por: De Mello, Ramon Andrade Bezerra, et al.
Publicado: (2021)

Advancements of ALK inhibition of non-small cell lung cancer: a literature review
por: Zia, Victor, et al.
Publicado: (2023)

Treatment Sequencing Strategies in Lung Cancer
por: Daniel Humberto Pozza,, et al.
Publicado: (2022)

MicroRNAs in Lung Cancer Oncogenesis and Tumor Suppression: How it Can Improve the Clinical Practice?
por: Pozza, Daniel Humberto, et al.
Publicado: (2020)

Biomarkers for Non-Small Cell Lung Cancer: From the Bench to the Bedside
por: de Mello, Ramon Andrade, et al.
Publicado: (2020)

CRISPR-based strategies in infectious disease diagnosis and therapy
por: Binnie, Alexandra, et al.
Publicado: (2021)

Comparative outcome assessment of epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of advanced non-small-cell lung cancer: a network meta-analysis
por: De Mello, Ramon Andrade, et al.
Publicado: (2017)

Epigenetic therapy in urologic cancers: an update on clinical trials
por: Faleiro, Inês, et al.
Publicado: (2016)

Screening for Colorectal Cancer Leading into a New Decade: The “Roaring ‘20s” for Epigenetic Biomarkers?
por: Almeida-Lousada, Hélder, et al.
Publicado: (2021)

MicroRNAs in lung cancer
por: Castro, Diana, et al.
Publicado: (2017)

Update in Immunotherapy for Advanced Non-Small Cell Lung Cancer: Optimizing Treatment Sequencing and Identifying the Best Choices
por: Roque, Katia, et al.
Publicado: (2023)

Potential role of immunotherapy in advanced non-small-cell lung cancer
por: de Mello, Ramon Andrade, et al.
Publicado: (2016)

Neural Signals Evoked by Stimuli of Increasing Social Scene Complexity Are Detectable at the Single-Trial Level and Right Lateralized
por: Amaral, Carlos P., et al.
Publicado: (2015)

Anaplastic lymphoma kinase gene rearrangement and non-small cell lung cancer management: a step forward in personalized therapy
por: De Mello, Ramon Andrade, et al.
Publicado: (2013)

Epidermal growth factor receptor mutation frequency and non-small cell lung cancer management: implication for treatment choices
por: De Mello, Ramon Andrade, et al.
Publicado: (2012)

Canonical WNT Signaling Pathway is Altered in Mesenchymal Stromal Cells From Acute Myeloid Leukemia Patients And Is Implicated in BMP4 Down-Regulation()
por: Azevedo, Pedro L., et al.
Publicado: (2019)

Subcorneal pustular dermatosis in the pediatric age
por: Jardim, Márcio Martins Lobo, et al.
Publicado: (2018)

Capmatinib in Japanese patients with MET exon 14 skipping–mutated or MET‐amplified advanced NSCLC: GEOMETRY mono‐1 study
por: Seto, Takashi, et al.
Publicado: (2021)

c-Met inhibitors
por: Mughal, Anum, et al.
Publicado: (2013)

Differential responses of MET activations to MET kinase inhibitor and neutralizing antibody
por: Kou, Jianqun, et al.
Publicado: (2018)

Memory and Cognition-Related Neuroplasticity Enhancement by Transcranial Direct Current Stimulation in Rodents: A Systematic Review
por: Cavaleiro, Carla, et al.
Publicado: (2020)

Biosynthesis of Chlorinated Lactylates in Sphaerospermopsis sp. LEGE 00249
por: Abt, Kathleen, et al.
Publicado: (2021)

Differential Pattern of Resistance and Sensitivity to Different Classes of MET Inhibitors for MET-Amplified Tumors With MET-D1228X or MET-Y1230X Mutations
por: Piper-Vallillo, Andrew J., et al.
Publicado: (2021)

MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified Non-Small Cell Lung Cancer
por: Ramesh, Shrey, et al.
Publicado: (2023)

Characterizing the roles of Met31 and Met32 in coordinating Met4-activated transcription in the absence of Met30
por: Carrillo, Emilio, et al.
Publicado: (2012)

Separability of motor imagery of the self from interpretation of motor intentions of others at the single trial level: an EEG study
por: Andrade, João, et al.
Publicado: (2017)

Identification of colorectal cancer associated biomarkers: an integrated analysis of miRNA expression
por: Fonseca, André, et al.
Publicado: (2021)

Correction for: Identification of colorectal cancer associated biomarkers: an integrated analysis of miRNA expression
por: Fonseca, André, et al.
Publicado: (2022)

Halophyte Plants as Potential Sources of Anticancer Agents: A Comprehensive Review
por: Custodio, Luísa, et al.
Publicado: (2022)

La reina sin nombre /
por: Gudín, María

Oxycodone DETERx(®): A Novel Abuse-Deterrent, Extended-Release Analgesic Option for the Treatment of Patients with Chronic Pain
por: Gudin, Jeff
Publicado: (2016)

MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors
por: Peng, Lun-Xi, et al.
Publicado: (2021)

Identification of MET fusions as novel therapeutic targets sensitive to MET inhibitors in lung cancer
por: Sun, Dantong, et al.
Publicado: (2023)

Detection of MET Polysomy by Next-generation Sequencing and Its Clinical Relevance for MET Inhibitors
por: Sun, Boyang, et al.
Publicado: (2023)

MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC Cells
por: Presutti, Dario, et al.
Publicado: (2015)

Isothiocyanatostilbenes as novel c-Met inhibitors
por: Gray, Alana L., et al.
Publicado: (2015)

Critical Role of MetR/MetB/MetC/MetX in Cysteine and Methionine Metabolism, Fungal Development, and Virulence of Alternaria alternata
por: Gai, Yunpeng, et al.
Publicado: (2021)

Novel c-Met inhibitor suppresses the growth of c-Met-addicted gastric cancer cells
por: Park, Chi Hoon, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_moflacj04mo5kf4e385v26l91b